RiverFront Investment Group’s Pfizer PFE Stock Holding History

RiverFront Investment Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	45,974 +2,440	+6%	+$63.8K	0.01%	226
2026 Q1	$1.22M	Buy	43,534 +19,485	+81%	+$519K	0.02%	184
2025 Q4	$599K	Buy	24,049 +6,466	+37%	+$163K	0.01%	216
2025 Q3	$448K	Buy	17,583 +5,636	+47%	+$139K	0.01%	227
2025 Q2	$290K	Buy	11,947 +2,138	+22%	+$49.9K	0.01%	255
2025 Q1	$249K	Buy	+9,809	New	+$257K	0.01%	256
2016 Q1	–	Sell	-788,401	Closed	-$24.1M	–	66
2015 Q4	$24.1M	Sell	788,401 -2,034	-0.3%	-$64K	0.7%	36
2015 Q3	$23.6M	Buy	790,435 +19,590	+3%	+$628K	0.68%	37
2015 Q2	$24.5M	Buy	770,845 +25,738	+3%	+$839K	0.67%	34
2015 Q1	$24.6M	Buy	+745,107	New	+$23.7M	0.69%	32

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RiverFront Investment Group's PFE Position: Q2 2026 in Review

RiverFront Investment Group increased its Pfizer (PFE) stake by 5.6% in Q2 2026, buying an estimated $63.8K and bringing the position to 45,974 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #226.

RiverFront Investment Group first reported a position in PFE in Q1 2015 and has held it in 10 quarters since. The position peaked at $24.6M in Q1 2015. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

RiverFront Investment Group held 45,974 shares of Pfizer worth $1.11M as of Q2 2026.
RiverFront Investment Group bought 2,440 Pfizer shares in Q2 2026, an estimated $63.8K.
Pfizer made up 0.01% of RiverFront Investment Group's portfolio in Q2 2026, its #226 holding.
RiverFront Investment Group first reported a position in Pfizer in Q1 2015 and has held it in 10 quarters since.
RiverFront Investment Group's Pfizer position peaked at $24.6M in Q1 2015.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.